Cas 128264-04-0,1-[2-Hydroxy-3-phenoxypropyl]-4-[4-[(methylsulfonyl)amino]benzoyl]piperazine phosphoric acid salt

128264-04-0

Post Buying Request

Basic information

Product Name: 1-[2-Hydroxy-3-phenoxypropyl]-4-[4-[(methylsulfonyl)amino]benzoyl]piperazine phosphoric acid salt
Synonyms:
CAS NO:128264-04-0
Molecular Formula:
Molecular Weight: 531.524
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-[2-Hydroxy-3-phenoxypropyl]-4-[4-[(methylsulfonyl)amino]benzoyl]piperazine phosphoric acid salt(CAS DataBase Reference)
NIST Chemistry Reference: 1-[2-Hydroxy-3-phenoxypropyl]-4-[4-[(methylsulfonyl)amino]benzoyl]piperazine phosphoric acid salt(128264-04-0)
EPA Substance Registry System: 1-[2-Hydroxy-3-phenoxypropyl]-4-[4-[(methylsulfonyl)amino]benzoyl]piperazine phosphoric acid salt(128264-04-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 128264-04-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

128264-04-0 Suppliers

Recommended suppliers

128264-04-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 128264-04-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,2,6 and 4 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 128264-04:
(8*1)+(7*2)+(6*8)+(5*2)+(4*6)+(3*4)+(2*0)+(1*4)=120
120 % 10 = 0
So 128264-04-0 is a valid CAS Registry Number.

128264-04-0Upstream product

128264-04-0Downstream Products

128264-04-0Relevant academic research and scientific papers

Derivatized alkanolamines as cardiovascular agents

-

, (2008/06/13)

Novel derivatized alkanolamines of the following structural formula STR1 are described as useful cardiovascular agents. Most especially described is their usefulness as cardiovascular agents exhibiting an antiarrhythmic effect. Said antiarrhythmic effect is of a combination Class II/Class III variety. Pharmaceutical formulations containing such compounds are also described.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 128264-04-0